COMPANY

Aponia Laboratories

HQ: Portsmouth, NH source · aponialabs.com ↗

The company is a specialized pharmaceutical company that is developing topical Rx (prescription) and over-the-counter (OTC) pain relief products in the $4.6 billion non-steroidal anti-inflammatory drugs (NSAIDs) segment of the $24.2 billion arthritis pain market. From company website Source · Oct 12, 2026

Keywords: From press sources: pain

Profile checked Oct 10, 2026

Funding and NIH signals

SEC Form D raise Filed a Form D, amount not stated (filed Sep 24, 2026). SEC Form D 0001497705-26-000003 (Sep 24, 2026)
Evidence (1 event)
- Sep 24, 2026 · SEC Form D 0001497705-26-000003
  Name of Issuer: Aponia Laboratories Inc; CIK: 1497705; Address: Portsmouth, NH; Submission type: D; Filing date: 2026-09-24; Industry Group: Other; Date of First Sale: Yet to Occur; Types of Securities Offered: Equity; Business combination transaction: false; Total Offering Amount: Indefinite; Total Amount Sold: 0; Federal exemptions: 06b

Job counts as of Oct 18, 2026. All funding and NIH signals